In Cell and Gene Therapy, Momentum Is Everything.

Companies in early-stage R&D developing cell or gene-based therapies operate with urgency—racing toward clinical milestones, funding rounds, and market entry in a high-stakes space where a few have succeeded. But even the most promising programs can be slowed by bottlenecks in production, format flexibility, raw material readiness, or regulatory alignment. 

Explore how to leverage adaptable systems and strategies designed to help you move faster, scale smarter, and reach your next milestone first.

Get Started With Sample Talk to an Expert

Sartorius Event

Sartorius Cell & Gene Therapy Forum, Boston, MA, October 23, 2025

Join us in Boston on October 23 for the Sartorius Cell & Gene Therapy Forum. Register now to secure your early-bird rate and connect with the experts shaping the future of cell and gene therapies.

Buy Ticket Here

Forward Momentum Against the Odds

From 14% to a Future With More

Snapshots of Success: Supporting the Unique Challenges of Early Stage

Explore quick snapshots of how innovative teams like yours are solving common challenges in early-stage cell and gene therapy development. From smarter scale-up strategies to simplified tech transfer, these real-world results showcase what’s possible when expertise and the right tools come together. Whether you're optimizing your upstream process or planning for clinical readiness, each story offers takeaways to help you move forward with confidence.

 

In-house Biopharma | US

Challenge: Non-scalable, open process step to remove cell aggregates

Solution: Scalable, closed filtration transfer set

Key Result: Significant improvement in operational efficiency with closed filtration solution integrated with subsequent unit operation

BioRestorative Therapies | US

Challenge: Rapid mycoplasma testing for high-density cell therapy products before QC release

Solution: Optimized PCR workflow with streamlined DNA extraction and detection

Key Result: Validated method cuts testing time from weeks to hours, enabling faster, reliable product release without compromising safety

HEALIOS K.K. | Japan

Challenge: Visualizing NK cell movement during cancer therapy research

Solution: Incucyte® SX5 Live-Cell Analysis System for high-throughput, cost-effective imaging

Key Result: Automated long-term imaging with parallel data analysis boosted efficiency and significantly reduced time and cost

There’s More to the Story When You Dive into the Data

Success Story

Real Results: Accelerating QC in Cell Therapy

See how a CGT innovator cut mycoplasma testing time from weeks to hours with a streamlined PCR-based QC workflow.

Investing in Future-Ready Technologies

Facilities Designed for Early-Stage Success

Marlborough, Massachusetts is the home of Sartorius’ new center for innovation. Designed to foster collaboration, co-development and learning on site with customers and other external innovation partners, this facility applies Sartorius' latest technologies in real-life bioprocess workflows.

Watch our video tour to see how we’re enabling early-stage cell and gene developers to break new ground with practical, future-ready technologies. 

  • Automated Cell Therapy Platform (01:34)
  • LNP Generation Tools (03:56)
  • Process Development & Clinical GMP Services (07:25) 
Head of Bioprocess Solutions Division

René Fáber

This cutting-edge innovation center enables us to leverage our bioprocessing tools and workflows expertise, ultimately accelerating and simplifying our customers’ path to clinical trials.

Reaching the Finish Line in Early-Stage Development

Building Better, Faster: Lessons from a Collaborative Development Journey

In early-stage development, achieving key milestones often means embracing agile strategies, strong partnerships, and moving beyond traditional process development methods. A prime example is the collaboration between Matica Biotechnology and Sartorius, which combined modular technologies and shared expertise to rapidly build and scale an AAV8 production platform. This effort was grounded in a “modular mindset” approaching each unit operation as part of a flexible, end-to-end system. Applying Quality by Design (QbD) principles in early-stage development sets the stage for successful scale-up, moving developers one step closer to regulatory approval.

 

Discover how this model broke barriers to success in three critical ways:

  1. Responding to market pressures for faster development, greater consistency, and GMP compliance.
  2. Adopting a modular mindset enabling plug-and-play development.
  3. GMP readiness by design – building in the expectations of regulatory agencies from the start.
  4. Accelerating timelines with important time-saving strategies like design-of-experiment (DoE) modeling.

Watch Webinar Now

Learn More

icon-multiple-choice

Request Your Sample | Raw Materials and Consumables

To help find the right materials and consumables for your needs, request a sample from our portfolio.

Request Your Sample

Explore Solutions by Modality

AAV Gene Therapy

Accelerate your AAV workflow with robust, scalable, and high-quality consumables, technologies, and services. 

Lentivirus Gene Therapy

Empower your lentivirus gene therapy process with solutions driven by performance, scalability, and quality.

Immune Cell Therapy

Empower your immune cell therapy process with solutions driven by reproducibility, scalability, and quality.

Stem Cell Therapy

Support each step of MSC, iPSC, and HSC workflows from discovery to commercialization.

Consult Our Experts

Consult Our Cell and Gene Therapy Experts